Leukemia inhibitory factor receptor (LIFR) expression is reduced in hepatocellular carcinoma, causing activation of NF-κB signaling through SHP1 and upregulation of the iron-chelating cytokine LCN2. The gene discussed is LIFR; the disease is hepatocellular carcinoma.